D305-0244 Screening compound: N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-3,4,5-trimethoxybenzamide

D305-0244 Screening compound: N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-3,4,5-trimethoxybenzamide
D305-0244 Screening compound: N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-3,4,5-trimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D305-0244
N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-3,4,5-trimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D305-0244

Molecular Formula

C26H35N5O4 (C26 H35 N5 O4)

Compound Name

N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}-3,4,5-trimethoxybenzamide

IUPAC name

N-{1-ethyl-2-[(4-ethylpiperazin-1-yl)methyl]-1H-13-benzodiazol-5-yl}-345-trimethoxybenzamide

SMILES

CCn1c(ccc(NC(c(cc2OC)cc(OC)c2OC)=O)c2)c2nc1CN1CCN(CC)CC1

InChI

InChI=1S/C26H35N5O4/c1-6-29-10-12-30(13-11-29)17-24-28-20-16-19(8-9-21(20)31(24)7-2)27-26(32)18-14-22(33-3)25(35-5)23(15-18)34-4/h8-9,14-16H,6-7,10-13,17H2,1-5H3,(H,27,32)

InChI Key

CESCJVOFADCUTL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09767122

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.876

Distribution Coefficient, logD

1.765

Water Solubility, LogSw

-3.32

Polar Surface Area

64.478

Acid Dissociation Constant (pKa)

12.50

Base Dissociation Constant (pKb)

8.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

D305-0244 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

CNS Targets (44014 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system

References: we are preparing a list of scientific research reports with D305-0244 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D305-0244?
Check Price and Availability of D305-0244, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D305-0244 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D305-0244
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D305-0244
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D305-0244 available by request